01 August 2021>: Articles
COVID-19 and Hepatic Artery Thrombosis: A Case Report
Unusual clinical course, Challenging differential diagnosis, Management of emergency care
Carlos Alexandre Antunes de Brito A* , José Ricardo Bandeira de Oliveira Filho A , Diogo Torres Marques A , Maria do Carmo Lencastre A , José Roberto de Almeida A , Edmundo Pessoa Lopes ADOI: 10.12659/AJCR.932531
Am J Case Rep 2021; 22:e932531
Table 1. Laboratory test results for the patient when the hepatic artery thrombosis was diagnosed.
Variable (normal values) | 16th day of illness |
---|---|
White blood cells 10/mm (4–10) | 8.760 |
Neutrophils 10/mm (1.6–7) | 5957 |
Lymphocytes 10/mm (1.5–4.5) | 1927 |
Hemoglobin g/dl (11.5–15) | 13,3 |
Platelets 10/mm (150–450) | 212 |
C-reactive protein mg/dl ( | 1,8 |
AST U/L (10–37) | 32 |
ALT U/L (5–45) | 25 |
Bilirubin mg/dl (0.3–1.2) | 0,8 |
Alkaline phosphatase U/L (46–116) | 75 |
Gamma GT U/L (1–24) | 56 |
LDH U/L (120–246) | 226 |
Lipase U/L (12–53) | 52 |
D-Dimer ng/ml ( | 2541 |
Fibrinogen mg/dl (200–400) | 454 |
Prothombin time ratio (0.80–1.2) | 1.0 |
Fator V de Leiden mutation R506Q | Absent |
Prothrombin G20210A mutation | Absent |
Anti-beta2 glycoprotein I (IgG) U/ml (negative | 2,9 |
Anti-beta2 glycoprotein I (IgM)U/ml (negative | |
Rheumatoid factor | Neg |
Antinuclear antibody | Neg |
Anticardiolipin IgG (GPL | 0,8 |
Homocysteine mcmol/L (4.4–13.56) | 13 |
Protein C% (70–140) | 130 |
Protein S% (72–112) | 110 |
Antithrombin (82–112%) | 89 |
ALT – alanine transaminase; gamma-GT – gamma-glutamyltransferase; LDH – lactate-dehydrogenase. |